Indian Pharma’s $250B 2030 Dream Threatened by Tariffs, Regulation
India's pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed…
India's pharmaceutical industry has set its sights on a $250 billion export target by 2030 — but according to Reuters, the sector is on track to miss that goal, squeezed…
India is the world's largest producer of generic medicines by volume, supplying over 20% of the global generic drug market. For buyers — whether hospitals, clinics, pharmacies, or individual patients…
India wants to be the "pharmacy of the world" — a $250 billion pharmaceutical export powerhouse supplying affordable generics to every corner of the globe. But a single structural problem…
Indian generic medicines account for a substantial share of global pharmaceutical supply — the US alone sources an estimated 40% of its generic prescription drug volume from India. With this…